These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17684486)

  • 1. Silencing the MET oncogene leads to regression of experimental tumors and metastases.
    Corso S; Migliore C; Ghiso E; De Rosa G; Comoglio PM; Giordano S
    Oncogene; 2008 Jan; 27(5):684-93. PubMed ID: 17684486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.
    Morello S; Olivero M; Aimetti M; Bernardi M; Berrone S; Di Renzo MF; Giordano S
    J Cell Physiol; 2001 Dec; 189(3):285-90. PubMed ID: 11748586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the wild-type and Y1235D mutant Met kinase activation.
    Cristiani C; Rusconi L; Perego R; Schiering N; Kalisz HM; Knapp S; Isacchi A
    Biochemistry; 2005 Nov; 44(43):14110-9. PubMed ID: 16245927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K; Nakamura T; Sakai K; Nakamura T
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
    Zou JN; Wang SZ; Yang JS; Luo XG; Xie JH; Xi T
    Cancer Lett; 2009 Jul; 280(1):78-85. PubMed ID: 19321255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.
    Ferracini R; Olivero M; Di Renzo MF; Martano M; De Giovanni C; Nanni P; Basso G; Scotlandi K; Lollini PL; Comoglio PM
    Oncogene; 1996 Apr; 12(8):1697-705. PubMed ID: 8622890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.
    Di Renzo MF; Olivero M; Giacomini A; Porte H; Chastre E; Mirossay L; Nordlinger B; Bretti S; Bottardi S; Giordano S
    Clin Cancer Res; 1995 Feb; 1(2):147-54. PubMed ID: 9815967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.
    Hansel DE; Rahman A; House M; Ashfaq R; Berg K; Yeo CJ; Maitra A
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6152-8. PubMed ID: 15448002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic engagement of the Met receptor is sufficient to evoke angiogenic, tumorigenic, and metastatic activities in rat intestinal epithelial cells.
    Bernier J; Chababi W; Pomerleau V; Saucier C
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G677-86. PubMed ID: 20539003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Met tyrosine kinase receptor in development and cancer.
    Gentile A; Trusolino L; Comoglio PM
    Cancer Metastasis Rev; 2008 Mar; 27(1):85-94. PubMed ID: 18175071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1.
    Matsushita A; Götze T; Korc M
    Cancer Res; 2007 Nov; 67(21):10309-16. PubMed ID: 17974973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive growth: a genetic program.
    Gentile A; Comoglio PM
    Int J Dev Biol; 2004; 48(5-6):451-6. PubMed ID: 15349819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.
    Lorenzato A; Olivero M; Patanè S; Rosso E; Oliaro A; Comoglio PM; Di Renzo MF
    Cancer Res; 2002 Dec; 62(23):7025-30. PubMed ID: 12460923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
    Salvi A; Arici B; Portolani N; Giulini SM; De Petro G; Barlati S
    Int J Oncol; 2007 Aug; 31(2):451-60. PubMed ID: 17611703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the MET oncogene in cancer and metastases.
    Stella GM; Benvenuti S; Comoglio PM
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1381-94. PubMed ID: 20868306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The coordinated functional expression of epidermal growth factor receptor and c-Met in colorectal carcinoma metastasis.
    Herynk MH; Radinsky R
    In Vivo; 2000; 14(5):587-96. PubMed ID: 11125542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
    De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
    J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
    Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
    Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.